Recharging aging cells by transferring mitochondria, the idea that changes everything

American researchers have developed an astonishing process: transferring mitochondria between cells to restore their energy. And it works!

The concept seems straight out of science fiction. However, it has just been demonstrated by a team of researchers from Texas A&M University: it is now possible to bring damaged or aged human cells back to life, simply by transferring new mitochondria to them. These tiny cellular structures, often called the cell’s “powerhouses,” are at the heart of this advance.

Led by Professor Akhilesh K. Gaharwar and doctoral student John Soukar, the study published in the journal Proceedings of the National Academy of Sciences offers a completely biological approach, without drugs or genetic modification. Thanks to “nanoflowers”, small particles shaped like microscopic flowers, healthy stem cells are encouraged to produce up to twice as many mitochondria. Once overloaded, they naturally transfer them to their damaged neighbors.

Damaged cells that regain energy and function

This process was tested on cells exposed to toxic chemical agents, such as those used in certain cancer treatments. Result: after receiving the new mitochondria, these cells regained their initial energy level and showed better resistance to cell death.

“We trained healthy cells to share their backup batteries with weaker ones”explained Professor Gaharwar.

“By increasing the number of mitochondria in donor cells, we can help aged or damaged cells regain their vitality – without any genetic modifications or drugs”he specifies.

This natural transfer of mitochondria between cells is not new, but until now it remained little exploited. With this technology, the phenomenon becomes four times more efficient. Enough to give rise to new hopes.

Towards targeted treatments for the heart, muscles or brain

The process could find applications in pathologies as diverse as myopathy, Alzheimer’s disease, cardiac damage or even the side effects of chemotherapy. One of the strengths of this technique is its ability to be localized.

“You can place the cells anywhere in the patient”explains John Soukar.

“For cardiomyopathy, you can target heart cells directly – placing the stem cells in or near the heart. For muscular dystrophy, they can be injected directly into the muscle.”he explains again.

Another advantage: the nanoparticles used in the manufacture of nanoflowers, based on molybdenum disulfide, remain in cells for a long time. Unlike traditional drug treatments, they do not require frequent doses. A monthly treatment might be enough.

“This is an exciting first step toward recharging aging tissues using their own biological machinery”concludes Gaharwar.

As research in regenerative medicine increasingly focuses on stem cells, this discovery could well mark a turning point. By boosting their ability to produce and share energy, Texas A&M researchers are charting a new path between cell therapy and bioenergy.

“It’s like giving an old electronic device a new battery. Rather than throwing it away, we plug in full batteries from healthy devices”illustrates Soukar.

Promising paths for the future

In his book The fascinating power of your mitochondriaDr Laurent Chevallier explores these essential but little-known organelles, true energy centers of our cells which maintain our body temperature, fuel our muscles and support our cognitive functions. It explains how to protect them from everyday toxic substances and strengthen them through a suitable diet, targeted supplements and exposure to certain light spectra, thus offering a practical guide to preserving vitality by taking care of these structures whose deterioration can lead to chronic fatigue, metabolic disorders and immune fragility.

“There are possibilities of transferring mitochondria from one cell to another and this is a real novelty, but we do not yet know precisely the underlying mechanisms. Mitochondrial transplants have already been carried out in the United States, although these practices remain poorly protocolized and insufficiently supervised scientifically.” reminds us of Dr. Chevallier.

Despite these current limitations, these approaches represent promising future avenues for regenerative medicine and the treatment of pathologies linked to mitochondrial dysfunction.